Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2023-02-28 Exercise |
2023-03-01 4:55 pm |
N/A N/A |
LEXICON PHARMACEUTICALS INC. | LXRX | Seth Kiernan VP, Chief Commercial Officer |
43,082 | $0 | 104,350 (Direct) |
View |
| 2023-02-28 Tax Withholding |
2023-03-01 4:55 pm |
N/A N/A |
LEXICON PHARMACEUTICALS INC. | LXRX | Seth Kiernan VP, Chief Commercial Officer |
11,813 | $2.17 | 104,350 (Direct) |
View |
| 2023-02-09 Option Award |
2023-02-13 5:04 pm |
N/A N/A |
LEXICON PHARMACEUTICALS INC. | LXRX | Seth Kiernan VP, Chief Commercial Officer |
373,470 | $0 | 373,470 (Direct) |
View |
| 2022-02-28 Exercise |
2022-02-28 7:17 pm |
N/A N/A |
LEXICON PHARMACEUTICALS INC. | LXRX | Seth Kiernan VP, Chief Commercial Officer |
30,128 | $0 | 47,273 (Direct) |
View |
| 2022-02-28 Tax Withholding |
2022-02-28 7:17 pm |
N/A N/A |
LEXICON PHARMACEUTICALS INC. | LXRX | Seth Kiernan VP, Chief Commercial Officer |
8,261 | $2.85 | 47,273 (Direct) |
View |
| 2022-02-10 Option Award |
2022-02-14 4:09 pm |
N/A 2032-02-10 |
LEXICON PHARMACEUTICALS INC. | LXRX | Seth Kiernan VP, Chief Commercial Officer |
275,560 | $0 | 275,560 (Direct) |
View |
Ownership |
2021-10-29 4:18 pm |
N/A 2025-02-05 |
LEXICON PHARMACEUTICALS INC. | LXRX | Seth Kiernan VP, Chief Commercial Officer |
0 | $0 | 241,082 (Direct) |
View |